Back to Search Start Over

Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update

Source :
PR Newswire. May 15, 2023
Publication Year :
2023

Abstract

TORRANCE, Calif., May 15, 2023 /PRNewswire/ --Emmaus Life Sciences, Inc.(OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PR Newswire
Publication Type :
News
Accession number :
edsgcl.749331032